
ヒューマン・メタボローム・テクノロジーズ株式会社(HMT)の2026年6月期決算および、新たに策定された5か年中期経営計画「TIAD-6(2026年7月〜2031年6月)」

Human Metabolome Technologies (6090) has released its financial results, reporting that operating income decreased by 15.9% year-on-year to 209 million yen. Net sales were 1,421 million yen (a 2.3% de